Skip to search formSkip to main contentSkip to account menu

EDTMP

Known as: Ethylenediamine Tetra(methylene Phosphonic Acid), LEXIDRONAM 
National Institutes of Health

Related topics

Related topics

1 relation
SAMARIUM Sm153 50 MCI/ML Injectable Solution [Quadramet]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
TWO LABELED EDTMP RADIOPHARMACEUTICALS WITH Sm-153 AND Lu-177 FOR HUMAN BONE RADIOTHERAPY
177Lu and 153Sm are perspective radionuclides used in nuclear medicine. High-energy beta particles and the relative half-life of… 
2011
2011
Phase II study of 153-samarium-EDTMP followed by haematopoietic stem cell for patients with osteosarcoma with bone metastasis.
10040 Background: Bone metastatic patients with osteosarcoma have a very poor prognosis. Targeted radiation therapy has been… 
Review
2009
Review
2009
Study of Samarium Lexidronam / Bortezomib Combination Therapy for theTreatment of Relapsed or Refractory Multiple Myeloma
Purpose: This open-label, phase I dose-escalation study assessed the safety, tolerability, and initial efficacyof Samariam153 (Sm… 
2006
2006
Evaluation of radiation levels of various syringe shields containing Sm-153 lexidronam
2005
2005
Repeated dose samarium 153 lexidronam in patients with prostate cancer bone metastases
4635 Background: Prospective randomized multi-center studies have demonstrated safety/efficacy of single 1.0 mCi/kg doses of… 
Review
2003
Review
2003
Targeting the Skeleton and Cancer in Bone Samarium treatment of osteosarcoma , osteoblastic bone metastases , and neoplastic disease in the bone marrow
the effectiveness of an intervention against cancer cells compared to normal tissue. Although chemotherapy and radiation are… 
2001
2001
Multiple myeloma
Multiple myeloma (MM) is a malignancy of the plasma cell characterized by migration and localization to the bone marrow where… 
1998
1998
Samarium Sm 153 lexidronam for the palliation of painful bone metastases
Samarium Sm 153 lexidronam has been shown in a series of clinical trials to be safe and effective for the treatment of painful… 
1976
1976
Double-labeling of experimental acute myocardial infarcts with 113mIn- and 99mTc-EDTMP.
The feasibility of double-labeling of acute myocardial infarcts with 113mIn-EDTMP [ethylenediaminetetra(methylene phosphonic acid… 
1975
1975
Indium-113m-labeled polyfunctional phosphonates as bone-imaging agents.
Indium-113m complexed with polyfunctional phosphonates EDTMP (an analog of EDTA with carboxylic groups replaced by phosphate…